Fol. Biol. 2013, 59, 15-25

https://doi.org/10.14712/fb2013059010015

Proteinuria and Hypertension in Patients Treated with Inhibitors of the VEGF Signalling Pathway – Incidence, Mechanisms and Management

Petra Tesařová1, V. Tesař2

1Department of Oncology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
2Department of Nephrology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Received August 2012
Accepted September 2012

Crossref Cited-by Linking

  • Eissa Ibrahim H., Elkady Hazem, Elgammal Walid E., Mahdy Hazem.A., Elkaeed Eslam B., Alsfouk Aisha A., Ibrahim Ibrahim M., Husein Dalal Z., Metwaly Ahmed M.: Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2. Journal of Molecular Structure 2024, 1312, 138641. <https://doi.org/10.1016/j.molstruc.2024.138641>
  • Santorsola Mariachiara, Capuozzo Maurizio, Nasti Guglielmo, Sabbatino Francesco, Di Mauro Annabella, Di Mauro Giordana, Vanni Gianluca, Maiolino Piera, Correra Marco, Granata Vincenza, Gualillo Oreste, Berretta Massimiliano, Ottaiano Alessandro: Exploring the Spectrum of VEGF Inhibitors\u2019 Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. Cancers 2024, 16, 350. <https://doi.org/10.3390/cancers16020350>
  • Eissa Ibrahim H., Yousef Reda G., Asmaey Mostafa A., Elkady Hazem, Husein Dalal Z., Alsfouk Aisha A., Ibrahim Ibrahim M., Elkady Mohamed A., Elkaeed Eslam B., Metwaly Ahmed M.: Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2. Saudi Pharmaceutical Journal 2023, 31, 101852. <https://doi.org/10.1016/j.jsps.2023.101852>
  • Elgammal Walid E., Elkady Hazem, Mahdy Hazem A., Husein Dalal Z., Alsfouk Aisha A., Alsfouk Bshra A., Ibrahim Ibrahim M., Elkaeed Eslam B., Metwaly Ahmed M., Eissa Ibrahim H.: Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC Adv. 2023, 13, 35853. <https://doi.org/10.1039/D3RA07562A>
  • Chehade Hassib, Cachat Francois, Beck-Popovic Maja, Rotman Samuel, Diezi Léonore, Albisetti Manuela, Alberio Lorenzo, Young Guy, Rizzi Mattia: Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child. Pediatrics 2020, 146. <https://doi.org/10.1542/peds.2020-0123>
Crossref Cited-by Linking logo